Cardinal Health (CAH) stock
NYSE
As of the Nov 5, 2026 close (U.S. Eastern)
Events and reference metrics · 1
- Market cap
- $61.9B
- As of Nov 5, 2026
- P/E
- 34.03x
- Trailing twelve months
- P/B
- Not available
- Latest reported equity
- P/S
- 0.24x
- Trailing twelve months
- ROE
- Not available
- Trailing twelve months
- Dividend yield
- 0.76%
- Latest fiscal-year dividends
Multiples use the price as of Nov 5, 2026 and may differ from the current price.
- Market cap
- $61.9B
- As of Nov 5, 2026
- P/E
- 34.03x
- Trailing twelve months
- P/B
- Not available
- Latest reported equity
- P/S
- 0.24x
- Trailing twelve months
- ROE
- Not available
- Trailing twelve months
- Dividend yield
- 0.76%
- Latest fiscal-year dividends
Multiples use the price as of Nov 5, 2026 and may differ from the current price.
Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.
Price date for the multiples · Nov 5, 2026 · Financial period · Trailing twelve months
P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock
P/E
34.03x
P/B
—
P/S
0.24x
Earnings and dividend metrics▾
Earnings
EPS
$7.87
Earnings per share
BPS
—
Book value per share
ROE
—
Return on equity
- EPS — what one share earned over the last four quarters. This company earned $7.87 per share.
Dividends
Yield
0.76%
Dividend per share
$2.04
Payout ratio
27.0%
Consecutive years
18+ yrs
Yield uses fiscal 2026 dividends · Dividend per share and payout ratio are for fiscal 2026.
- Dividend yield — dividends divided by the share price (or market cap). It falls when the price rises.
- Dividend per share — the fiscal-year dividend per share. For one hundred shares that is about $204.00 before tax.
- Payout ratio — 27.0% of earnings was paid out as dividends.
- Consecutive years — dividends were paid every year for more than 18 years. That does not mean they will continue.
Reference only · not a promise of future dividends
ⓘ What are these valuation metrics?▾
P/E = share price ÷ earnings per share (EPS)
P/B = share price ÷ book value per share (BPS)
P/S = share price ÷ sales per share
P/E shows how many times annual earnings per share the price is; not all earnings are paid to shareholders. P/B compares the price with net assets, and P/S with sales.
Higher or lower is not good or bad by itself. Typical levels differ by industry; read P/B alongside ROE and P/S alongside margins.
ChickenStock computes these from SEC financial filings: net income and revenue are summed over the latest four quarters, and equity is the latest reported balance.
A negative P/E means a net loss. Reference information only, not a recommendation to buy or sell.
Latest earnings
SEC filingsJul–Sep 2026(FY2027 Q1)
Revenue increased 5.5% from the same period a year earlier.
Key reported figures come first. Select one to see the same quarter across three years.
Revenue · same quarter, three years
Year-ago quarter $64B+5.5%
$52.3B
Jul–Sep '24
$64B
Jul–Sep '25
$67.5B
Jul–Sep '26
The next earnings date has not been confirmed yet.
ⓘ Notes on these figures▾
- Results for Jul–Sep 2026 are from the 10-Q submitted to SEC EDGAR on Nov 5, 2026.
- Earnings per share increased 26.6% from the same quarter a year earlier.
- Revenue increased 5.5% from the same quarter a year earlier.
- Operating income increased 12.7% from the same quarter a year earlier.
- Net income increased 23.1% from the same quarter a year earlier.
Filed Nov 5, 2026 · 10-Q · SEC EDGAR · View original
Reported results are from SEC EDGAR filings. Reference information only, not investment advice.
Insider transactions
Recent Form 4 filings grouped by person, date and transaction type.
- Hollar Jason M.Chief Executive Officer · Aug 19, 2026Open-market sale44,529 shares · $10.5MAvg. price $236.1755
Show 6 price lots
- 16,187 shares × $237.23$3.8M
- 6,731 shares × $236.46$1.6M
- 6,244 shares × $237.88$1.5M
- 6,206 shares × $233.22$1.4M
- 5,704 shares × $235.34$1.3M
- 3,457 shares × $234.29$810K
- Scherer Mary C.Chief Accounting Officer · Aug 19, 2026Open-market sale2,302 shares · $546KAvg. price $237.3904
Show 2 price lots
- 2,202 shares × $237.39$523K
- 100 shares × $237.4$24K
- Hollar Jason M.Chief Executive Officer · Aug 18, 2026Open-market sale80,000 shares · $18.9MAvg. price $235.7357
Show 4 price lots
- 29,915 shares × $235.51$7.0M
- 21,407 shares × $234.56$5.0M
- 16,208 shares × $236.54$3.8M
- 12,470 shares × $237.25$3.0M
- Alt Aaron EChief Financial Officer · Aug 18, 2026Open-market sale42,000 shares · $9.9MAvg. price $236.3367
Show 4 price lots
- 13,685 shares × $236.58$3.2M
- 12,972 shares × $237.26$3.1M
- 12,228 shares × $235.54$2.9M
- 3,115 shares × $234.55$731K
- Mason Stephen MCEO, GMPD Segment · Aug 18, 2026Open-market sale35,000 shares · $8.3MAvg. price $236.4034
Show 4 price lots
- 12,829 shares × $237.26$3.0M
- 10,876 shares × $236.5$2.6M
- 8,195 shares × $235.62$1.9M
- 3,100 shares × $234.59$727K
- Mayer Jessica LChief Legal/Compliance Officer · Aug 18, 2026Open-market sale29,436 shares · $7.0MAvg. price $236.1899
Show 4 price lots
- 10,864 shares × $237.31$2.6M
- 10,246 shares × $235.51$2.4M
- 4,426 shares × $236.38$1.0M
- 3,900 shares × $234.64$915K
- WEITZMAN DEBORAHCEO, PSS Segment · Aug 18, 2026Open-market sale7,354 shares · $1.7MAvg. price $235.4533
Show 3 price lots
- 6,665 shares × $235.3$1.6M
- 408 shares × $236.59$97K
- 281 shares × $237.44$67K
- Greene Michelle D.Chief Information Officer · Aug 18, 2026Open-market sale11,650 shares · $2.7MAvg. price $235.7242
Show 4 price lots
- 4,952 shares × $235.68$1.2M
- 3,512 shares × $236.31$830K
- 2,500 shares × $234.57$586K
- 686 shares × $237.25$163K
- Hollar Jason M.Chief Executive Officer · Aug 15, 2026Shares withheld for taxes103,449 shares · $24.3MAvg. price $235.17315,132 shares held after
- Alt Aaron EChief Financial Officer · Aug 15, 2026Shares withheld for taxes30,730 shares · $7.2MAvg. price $235.1762,495 shares held after
- WEITZMAN DEBORAHCEO, PSS Segment · Aug 15, 2026Shares withheld for taxes29,759 shares · $7.0MAvg. price $235.1785,255 shares held after
- Mason Stephen MCEO, GMPD Segment · Aug 15, 2026Shares withheld for taxes25,289 shares · $5.9MAvg. price $235.1753,061 shares held after
- Mayer Jessica LChief Legal/Compliance Officer · Aug 15, 2026Shares withheld for taxes25,285 shares · $5.9MAvg. price $235.1762,512 shares held after
- Greene Michelle D.Chief Information Officer · Aug 15, 2026Shares withheld for taxes10,031 shares · $2.4MAvg. price $235.1721,980 shares held after
- Pitteroff Valerie ChristineChief Human Resources Officer · Aug 15, 2026Shares withheld for taxes1,852 shares · $436KAvg. price $235.1711,757 shares held after
- Scherer Mary C.Chief Accounting Officer · Aug 15, 2026Shares withheld for taxes1,757 shares · $413KAvg. price $235.175,113 shares held after
- Hollar Jason M.Chief Executive Officer · Aug 15, 2026Grant or award30,616 shares · $0Avg. price $0418,581 shares held after
Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.
Recent SEC filings
40 filingsRecent filing summaries
Newest first by publication date · may differ from the filing date
- AI summary8-KCardinal Health said on October 1, 2026 it entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032. The company said the extension reflects the continuation of its current scope of distribution services.Published Oct 1, 2026 · Filed Oct 1, 2026Read the summary →
- AI summary8-KCardinal Health said shareholders elected 12 nominees to the Company's Board of Directors at the 2025 Annual Meeting of Shareholders, each to serve until the 2026 Annual Meeting of Shareholders.Published Oct 12, 2026 · Filed Nov 6, 2025Read the summary →
- AI summary8-KThe company said revenue for fiscal 2026 Q1 rose to $64.0 billion from $52.3 billion a year earlier, an increase of 22%. GAAP operating earnings increased 18% to $668 million.Published Oct 7, 2026 · Filed Oct 30, 2025Read the summary →
Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.
Company overview
Expand ▾
Cardinal Health (CAH) stock information
NYSE
Cardinal Health (CAH) is listed on NYSE. Its market capitalization is about $61.9B. On trailing-twelve-month earnings the P/E ratio is 34.03. These figures are computed in-house from official filings and are reference information only.
Cardinal Health — frequently asked questions
- What is the P/E ratio of Cardinal Health (CAH)?
- On a trailing-twelve-month basis, CAH trades at a P/E ratio of 34.03. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
- What is the market capitalization of Cardinal Health?
- CAH has a market capitalization of about $61.9B. The figure moves with the share price and is refreshed each trading day.
- Does Cardinal Health pay a dividend?
- CAH has a dividend yield of about 0.76%, based on disclosed payment history. Dividend policy can change; this is reference information only.
- Is this page investment advice?
- No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.